IL6 and neoplasm: Previous studies have shown that carcinogen-induced tumorigenesis in IL-6−/− mice is delayed by 1-2 weeks [4,47]; however, we found no difference in KrasG12D-induced tumor onset regardless of IL-6 deficiency.